Quantcast

Latest Intensive insulinotherapy Stories

2010-09-21 10:00:00

STOCKHOLM, Sept. 21 /PRNewswire/ -- More than one in three diabetes patients skip doses or fail to take their insulin as prescribed, stating that they have done so on average three times in the last month, and 77 percent of physicians estimate that in reality this number could be as high as six doses*, according to the Global Attitudes of Patients and Physicians in Insulin Therapy (GAPP(TM)) survey, released today by Novo Nordisk. The global survey, conducted in eight countries among...

2010-09-02 06:30:00

SAN DIEGO, Sept. 2 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) today announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog®, and insulin lispro, the active ingredient in Humalog®. Diabetes patients enrolled in these cross-over design studies...

2010-08-04 14:00:00

INDIANAPOLIS, Aug. 4 /PRNewswire/ -- Roche Diabetes Care, makers of the ACCU-CHEK® portfolio of diabetes management products and services, is pleased to announce the inaugural National Infusion Site Awareness Week, Aug. 30-Sept. 5. Roche made the announcement during the 37th annual American Association of Diabetes Educators (AADE) conference to highlight the important role that certified diabetes educators and other health care professionals play in promoting better site...

2010-06-28 11:00:00

ORLANDO, Fla., June 28 /PRNewswire-FirstCall/ -- Today Novo Nordisk announced results of its STEPwise(TM) trial, which identified a method of intensifying insulin treatment with NovoLog® (insulin aspart [rDNA origin] injection). The study, presented at the American Diabetes Association (ADA) 2010 Scientific Sessions, demonstrated a reduction of A1c levels in type 2 diabetes patients when a dose of NovoLog® was introduced at meals, using two approaches...

2010-06-25 17:15:00

ORLANDO, Fla., June 25 /PRNewswire-FirstCall/ -- Novo Nordisk today presented phase 2 proof-of-concept data for its investigational insulin degludec, an ultra-long-acting basal insulin, which demonstrated the potential to help achieve target glycemic control when used once daily or three times weekly. These data were presented at the 70th Scientific Sessions of the American Diabetes Association (ADA).(1) These phase 2 studies showed that insulin degludec helped improve glucose control. In...

2010-02-05 08:30:00

-- Research Shows Closed-Loop Systems Control Diabetes, Reduce Dangerous Low Blood Sugar -- LONDON, Feb. 5 /PRNewswire-USNewswire/ -- In a landmark study in children and teenagers with type 1 diabetes, JDRF-funded researchers at the University of Cambridge showed that using a first-generation artificial pancreas system overnight can lower the risk of low blood sugar emergencies while sleeping, and at the same time improve diabetes control. Results from the studies are published in the...

2010-01-26 15:46:01

Treating adults with septic shock with intensive insulin therapy to counter elevated blood glucose levels associated with corticosteroid therapy did not result in a reduced risk of in-hospital death, compared to patients who received conventional insulin therapy, according to a study in the January 27 issue of JAMA. The researchers also found that adding a 2nd corticosteroid to treatment did not significantly reduce the risk of death within the hospital. Septic shock is a major complication...

2009-12-01 17:22:00

NEW YORK, Dec . 1 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Insulin Pumps (External) - A World Market Review http://www.reportlinker.com/p0164247/Insulin-Pumps-External---A-World-Market-Review.html Insulin pumps, also called Continuous Subcutaneous Insulin Infusion (CSII), provide better control over diabetes, when compared to other forms of treatment. Insulin pump is a pager-sized battery operated handy device, which is...

2009-11-19 07:00:00

Primary Care Doctors, Endocrinologists Feel Ill-Equipped to Provide Ideal, Multi-Disciplinary Team Care PRINCETON, N.J., Nov. 19 /PRNewswire/ -- Nearly one-third of doctors surveyed said they did not have enough time and did not receive sufficient reimbursement to provide comprehensive care to their patients with diabetes, according to the results of a study of endocrinologists and primary care doctors published today in American Health & Drug Benefits. An online survey of 300...

2009-09-09 09:39:40

Studies link improvements in diabetes control to frequency of use and demonstrate continued improvements 12 months after use, with 'remarkably low' occurrence of severe hypoglycemia The latest data from groundbreaking human clinical trials of the effectiveness of continuous glucose monitors (CGM) show that the primary determinant of improvements in achieving better diabetes control is regular use of monitors "“ six days per week or more "“ rather than the age of patients, and that...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.